Jump to content

Page values for "Triamcinolone"

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericStringTriamcinolone (acetonide and other esters)
brandStringKenalog (injectable), Nasacort (intranasal), Aristocort (topical), Trianex
structureFile
classesList of String, delimiter: ,[[:Category:Corticosteroids|Corticosteroid]] [[:Category:Glucocorticoids|Glucocorticoid (intermediate-acting)]]
mechanismString
usesString'"`UNIQ--vote-00000661-QINU`"', '"`UNIQ--vote-00000662-QINU`"', '"`UNIQ--vote-00000663-QINU`"', '"`UNIQ--vote-00000664-QINU`"', '"`UNIQ--vote-00000665-QINU`"'
starting_doseStringTopical 0.025-0.5% cream/ointment BID; intra-articular 5-40 mg per joint q3-6 months; intranasal Nasacort 110 mcg/spray, 2 sprays/nostril daily; oral paste 0.1% to lesion 2-3×/d
preparationsStringTopical creams, ointments, lotions, dental paste (0.025-0.5%); Kenalog 10 mg/mL, 40 mg/mL injection; Nasacort 55 mcg/spray intranasal; oral inhaler discontinued in US
fda_maxStringIndication-specific
pill_idText
routesList of String, delimiter: ,Topical intra-articular intralesional intramuscular intranasal oral paste
onsetStringTopical hours; intra-articular days to weeks
durationStringIntra-articular 3-6 months (depot effect of acetonide microcrystals)
halflifeStringPlasma ~3-5 hours; biologic effect substantially longer (~12-36 hours for intermediate-acting glucocorticoids)'"`UNIQ--ref-00000666-QINU`"'
bioavailabilityStringTopical/intranasal: high local, low systemic; intra-articular: local depot then systemic absorption'"`UNIQ--ref-00000667-QINU`"'
pregnancyStringTopical/intranasal generally low-risk; intra-articular and high-dose injection: weigh risk individually.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup>
legalStringOTC (lowest-strength topicals) and [[USLegal:Prescription only|Rx-only]] (higher strengths, injectable) in US